文献速递中医内科中药与中成药合理使用

西红花的植物化学、药理与潜在临床应用综述

Phytochemistry, pharmacology, and potential clinical applications of saffron: A review.
PubMed 文献 · J Ethnopharmacol · 2021-08-23

本文系统综述西红花(Crocus sativus)的化学成分、药理活性及临床应用。共揭示150余种化合物,药理研究集中于抗氧化、抗炎、抗肿瘤、抗抑郁、降糖、降脂及增强记忆等;临床研究主要针对阿尔茨海默病、抑郁和焦虑障碍。结论认为需大量临床试验验证其对高血压、高脂血症及癌症等其他疾病的疗效,并需进一步研究作用机制、毒理及有效剂量。

要点

  • 西红花含150余种化合物,药理活性广泛,包括抗氧化、抗炎、抗抑郁等。
  • 现有临床研究主要集中于阿尔茨海默病、抑郁和焦虑障碍。
  • 需更多临床试验验证对其他疾病(如高血压、高脂血症、癌症)的疗效及有效剂量与长期毒性。

核心结论

  • 西红花的植物化学与药理作用已较明确,但临床研究主要集中在阿尔茨海默病、抑郁和焦虑障碍。
  • 仍需大量临床试验验证西红花及其主要成分对高血压、高脂血症和癌症等其他疾病的疗效。
  • 需进一步研究西红花的作用机制、毒理特性,尤其需建立有效剂量和长期体内毒性数据。

研究设计与样本

  • 综述类研究,通过Web of Science、Google Scholar、Science Direct、PubMed、SpringerLink、Wiley Online Library、SciFinder、Chemical book及CNKI等数据库收集相关文献,并参考中药经典书籍。

主要发现

  • 西红花中已发现超过150种化合物,包括类胡萝卜素、黄酮及黄酮苷、单萜及单萜衍生物、单环芳香烃、氨基酸、生物碱等。
  • 药理活性研究集中于抗氧化、抗炎、抗肿瘤、抗抑郁、降血糖、降血脂、增强记忆等。
  • 目前西红花主要用于糖尿病、阿尔茨海默病、抑郁、焦虑障碍、心血管疾病、学习记忆障碍、癌症等疾病的治疗。

临床怎么用

  • 临床可参考西红花在抑郁、焦虑障碍及阿尔茨海默病方面的现有研究证据,但用于其他疾病需谨慎。
  • 使用西红花时应关注其有效剂量和长期毒性尚未充分确立的问题。

局限性

  • 临床研究主要集中在阿尔茨海默病、抑郁和焦虑障碍,对其他疾病的疗效证据不足。
  • 西红花的作用机制和毒理特性尚需进一步研究,尤其缺乏有效剂量和长期体内毒性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Saffron, the dried red stigma of the perennial herb Crocus sativus L. (Iridaceae), is one of the most important and expensive spices in the world. It is used as a traditional Chinese medicine with demonstrated effects in promoting blood circulation and suppressing blood stasis, cooling blood detoxification, and relieving depression. It is mainly used for the treatment of depression, irregular menstruation, postpartum thrombosis, and bruises. AIM OF THE STUDY: This review aims to provide a systematic and up-to-date overview of the phytochemistry, pharmacology, and clinical applications of saffron. We hope it could provide useful references and guidance for the future directions of research on saffron. MATERIALS AND METHODS: The online database, such as Web of Science, Google Scholar, Science Direct, PubMed, SpringerLink, Wiley Online Library, SciFinder and Chemical book, and CNKI were used to collect relevant literature. And the classic books about Chinese herbal medicine were also being referenced. RESULTS: More than 150 chemical compounds, including carotenoids, flavonoids and flavonoid glycosides, monoterpenes and monoterpenoid derivatives, monocyclic aromatic hydrocarbons, amino acids, alkaloids and others, were revealed. The pharmacological activities study of saffron were focused on the antioxidant, anti-inflammatory, antitumor, antidepressant, hypoglycemic, hypolipidemic, memory-enhancing, and so on. Currently, saffron is mainly used for the treatment of diabetes, Alzheimer's disease, depression, anxiety disorders, cardiovascular diseases, learning and memory disorders, cancer, and other conditions. CONCLUSIONS: Phytochemical and pharmacological analyses of saffron have been revealed in recent studies. However, clinical studies have focused mainly on AD, depression and anxiety disorders. Therefore, a large number of clinical trials are needed to study the efficacy of saffron and its major chemical components against other diseases including hypertension, hyperlipidemia, and cancer. Further studies of the mechanism of action and toxicological properties of saffron are also required, especially research to establish an effective dose of saffron and its long-term toxicity in vivo.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Xing B, Li S, Yang J, et al. Phytochemistry, pharmacology, and potential clinical applications of saffron: A review. J Ethnopharmacol. 2021. PMID: 34438035. doi:10.1016/j.jep.2021.114555

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。